{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:17:21Z","timestamp":1789903041743,"version":"4.0.1"},"reference-count":141,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,5,8]]},"DOI":"10.3233\/jad-180005","type":"journal-article","created":{"date-parts":[[2018,4,29]],"date-time":"2018-04-29T11:38:02Z","timestamp":1525001882000},"page":"899-910","source":"Crossref","is-referenced-by-count":48,"title":["Behavioral and Neuropsychiatric Disorders in Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"63","author":[{"given":"Nicole","family":"Cort\u00e9s","sequence":"first","affiliation":[{"name":"International Center for Biomedicine (ICC), Santiago, Chile"},{"name":"Laboratory of Cellular and Molecular Neurosciences, Faculty of Sciences, University of Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Andrade","sequence":"additional","affiliation":[{"name":"International Center for Biomedicine (ICC), Santiago, Chile"},{"name":"Laboratory of Cellular and Molecular Neurosciences, Faculty of Sciences, University of Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo B.","family":"Maccioni","sequence":"additional","affiliation":[{"name":"International Center for Biomedicine (ICC), Santiago, Chile"},{"name":"Laboratory of Cellular and Molecular Neurosciences, Faculty of Sciences, University of Chile, Santiago, Chile"},{"name":"Department of Neurological Sciences, Faculty of Medicine, East Campus, University of Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180005_ref1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180005_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-180005_ref3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.ejhg.5201946","article-title":"Expanded high-resolution genetic study of 109 Swedish families with Alzheimer\u2019s disease","volume":"16","author":"Sillen","year":"2008","journal-title":"Eur J Hum Genet"},{"key":"10.3233\/JAD-180005_ref4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nri1843","article-title":"Immunology and immunotherapy of Alzheimer\u2019s disease","volume":"6","author":"Weiner","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.3233\/JAD-180005_ref5","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1093\/hmg\/ddq142","article-title":"Current status on Alzheimer disease molecular genetics: From past, to present, to future","volume":"19","author":"Bettens","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-180005_ref6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.3233\/JAD-180005_ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2012.11.006","article-title":"The worldwide economic impact of dementia 2010","volume":"9","author":"Wimo","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180005_ref8","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.3233\/JAD-180005_ref9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1126\/science.1067122","article-title":"Toxic proteins in neurodegenerative disease","volume":"296","author":"Taylor","year":"2002","journal-title":"Science"},{"key":"10.3233\/JAD-180005_ref10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0188-4409(01)00316-2","article-title":"The molecular bases of Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"32","author":"Maccioni","year":"2001","journal-title":"Arch Med Res"},{"key":"10.3233\/JAD-180005_ref11","doi-asserted-by":"crossref","first-page":"226ra230","DOI":"10.1126\/scitranslmed.3007901","article-title":"Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease","volume":"6","author":"Fagan","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-180005_ref12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-180005_ref13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2014.00112","article-title":"Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches","volume":"8","author":"Morales","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-180005_ref14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2008.03972.x","article-title":"The role of neuroimmunomodulation in Alzheimer\u2019s disease","volume":"1153","author":"Maccioni","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-180005_ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2007.10.001","article-title":"Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer\u2019s disease","volume":"39","author":"Rojo","year":"2008","journal-title":"Arch Med Res"},{"key":"10.3233\/JAD-180005_ref16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-2008-14307","article-title":"The damage signals hypothesis of Alzheimer\u2019s disease pathogenesis","volume":"14","author":"Fernandez","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180005_ref17","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nn.4608","article-title":"Necroptosis activation in Alzheimer\u2019s disease","volume":"20","author":"Caccamo","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-180005_ref18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2013moving from amyloid-beta to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-180005_ref19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180005_ref20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180005_ref21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180005_ref22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/JGP.0b013e3181faec23","article-title":"Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: The Cache County Dementia Progression study","volume":"19","author":"Tschanz","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-180005_ref23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/alzrt48","article-title":"Review of Alzheimer\u2019s disease scales: Is there a need for a new multi-domain scale for therapy evaluation in medical practice?","volume":"2","author":"Robert","year":"2010","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-180005_ref24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","article-title":"Biomarkers for Alzheimer\u2019s disease: Academic, industry and regulatory perspectives","volume":"9","author":"Hampel","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-180005_ref25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1017\/S0317167100003917","article-title":"Progress in clinical neurosciences: Cognitive markers of progression in Alzheimer\u2019s disease","volume":"32","author":"Behl","year":"2005","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JAD-180005_ref26","doi-asserted-by":"crossref","first-page":"a006148","DOI":"10.1101\/cshperspect.a006148","article-title":"The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment","volume":"2","author":"Tarawneh","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-180005_ref27","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0733-8619(05)70228-0","article-title":"Neurobehavioral and neuropsychiatric symptoms in Alzheimer\u2019s disease: Characteristics and treatment","volume":"18","author":"Chung","year":"2000","journal-title":"Neurol Clin"},{"key":"10.3233\/JAD-180005_ref28","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1212\/WNL.0000000000003916","article-title":"Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease","volume":"88","author":"Ng","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-180005_ref29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.0000000000001238","article-title":"\u201cNoncognitive\u201d symptoms of early Alzheimer disease: A longitudinal analysis","volume":"84","author":"Masters","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-180005_ref30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrneurol.2009.39","article-title":"Management of agitation and aggression associated with Alzheimer disease","volume":"5","author":"Ballard","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-180005_ref31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3233\/JAD-140309","article-title":"Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"41","author":"Vermeiren","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180005_ref32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/gps.1025","article-title":"The persistence of neuropsychiatric symptoms in dementia: The Cache County Study","volume":"19","author":"Steinberg","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-180005_ref33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000017113","article-title":"Behavioral syndromes in Alzheimer\u2019s disease: Description and correlates","volume":"10","author":"Frisoni","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-180005_ref34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3233\/JAD-160675","article-title":"The effect of the association between donepezil and choline alphoscerate on behavioral disturbances in Alzheimer\u2019s disease: Interim results of the ASCOMALVA trial","volume":"56","author":"Carotenuto","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180005_ref35","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1176\/ajp.147.8.1049","article-title":"Psychiatric symptoms and nursing home placement of patients with Alzheimer\u2019s disease","volume":"147","author":"Steele","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-180005_ref36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","article-title":"The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s disease: Systematic review and meta-analysis","volume":"190","author":"Zhao","year":"2016","journal-title":"J Affect Disord"},{"key":"10.3233\/JAD-180005_ref37","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2147\/NDT.S47133","article-title":"Behavioral symptoms related to cognitive impairment","volume":"9","author":"Dillon","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.3233\/JAD-180005_ref38","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","article-title":"Neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"7","author":"Lyketsos","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180005_ref39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3233\/JAD-150944","article-title":"Delusions in patients with Alzheimer\u2019s disease: A multidimensional approach","volume":"51","author":"D\u2019Onofrio","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180005_ref40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fneur.2012.00073","article-title":"Behavioral and psychological symptoms of dementia","volume":"3","author":"Cerejeira","year":"2012","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-180005_ref41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.46.1.130","article-title":"The spectrum of behavioral changes in Alzheimer\u2019s disease","volume":"46","author":"Mega","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JAD-180005_ref42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1159\/000137671","article-title":"Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer\u2019s disease","volume":"25","author":"Skogseth","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-180005_ref43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000090674","article-title":"Neuropathologic correlates of apathy in Alzheimer\u2019s disease","volume":"21","author":"Marshall","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-180005_ref44","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.trci.2017.07.001","article-title":"Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: New treatment paradigms","volume":"3","author":"Lanct\u00f4t","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-180005_ref45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jalz.2016.05.008","article-title":"Apathy associated with neurocognitive disorders: Recent progress and future directions","volume":"13","author":"Lanctot","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180005_ref46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JAD-2012-112003","article-title":"Apathy and depression in mild Alzheimer\u2019s disease: A cross-sectional study using diagnostic criteria","volume":"31","author":"Benoit","year":"2012","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-180005_ref47","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1586\/ern.09.106","article-title":"What is the association between depression and Alzheimer\u2019s disease?","volume":"9","author":"Tsuno","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JAD-180005_ref48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JGP.0b013e31816029ec","article-title":"Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression","volume":"16","author":"Rapp","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-180005_ref49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.63.2.161","article-title":"Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression","volume":"63","author":"Rapp","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-180005_ref50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.b.10068","article-title":"Depression in Alzheimer\u2019s disease: The effect of serotonin receptor gene variation","volume":"119B","author":"Holmes","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.3233\/JAD-180005_ref51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000112509","article-title":"Neuropsychiatric manifestations in mild cognitive impairment: A systematic review of the literature","volume":"25","author":"Apostolova","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-180005_ref52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1017\/S0033291712001870","article-title":"Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment","volume":"43","author":"Ramakers","year":"2013","journal-title":"Psychol Med"},{"key":"10.3233\/JAD-180005_ref53","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000363500","article-title":"Agitation in dementia: Relation to core cerebrospinal fluid biomarker levels","volume":"4","author":"Bloniecki","year":"2014","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.3233\/JAD-180005_ref54","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.72","article-title":"Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease","volume":"49","author":"Tekin","year":"2001","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-180005_ref55","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuint.2005.11.002","article-title":"Neuropsychological and behavioural correlates of CSF biomarkers in dementia","volume":"48","author":"Engelborghs","year":"2006","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-180005_ref56","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/brain\/awh129","article-title":"Disrupted daily activity\/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer\u2019s dementia","volume":"127","author":"Hatfield","year":"2004","journal-title":"Brain"},{"key":"10.3233\/JAD-180005_ref57","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/153331750502000611","article-title":"Prevalence and clinical correlates of neuropsychiatric symptoms in dementia","volume":"20","author":"Steffens","year":"2005","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.3233\/JAD-180005_ref58","first-page":"105","article-title":"Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer\u2019s disease","volume":"2","author":"Allegri","year":"2006","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.3233\/JAD-180005_ref59","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/gps.2795","article-title":"Cognitive and behavioural predictors of survival in Alzheimer disease: Results from a sample of treated patients in a tertiary-referral memory clinic","volume":"27","author":"Russ","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-180005_ref60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/JGP.0b013e3181e446c8","article-title":"Trajectory of cognitive decline as a predictor of psychosis in early Alzheimer disease in the cardiovascular health study","volume":"19","author":"Emanuel","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-180005_ref61","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3233\/JAD-131166","article-title":"Hyperphosphorylated tau is elevated in Alzheimer\u2019s disease with psychosis","volume":"39","author":"Murray","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.3233\/JAD-180005_ref62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/archneur.1991.00530180075020","article-title":"Neuropathologic and neurochemical correlates of psychosis in primary dementia","volume":"48","author":"Zubenko","year":"1991","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-180005_ref63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.JGP.0000239263.52621.97","article-title":"Predictive validity of neuropsychiatric subgroups on nursing home placement and survival in patients with Alzheimer disease","volume":"15","author":"Tun","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-180005_ref64","first-page":"212","article-title":"[Neuropsychiatric and behavioral symptomatology in Alzheimer disease]","volume":"38","author":"Garcia-Alberca","year":"2010","journal-title":"Actas Esp Psiquiatr"},{"key":"10.3233\/JAD-180005_ref65","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1440-1819.2000.00773.x","article-title":"Neurobiological basis of behavioral and psychological symptoms in dementia of the Alzheimer type","volume":"54","author":"Shinosaki","year":"2000","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-180005_ref66","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1212\/01.wnl.0000436940.78152.05","article-title":"CSF biomarkers of Alzheimer disease: \u201cnoncognitive\u201d outcomes","volume":"81","author":"Roe","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-180005_ref67","first-page":"1031","article-title":"An overview of the links between behavioral disorders and Alzheimer\u2019s disease","volume":"4","author":"Andrade Victor","year":"2017","journal-title":"JSM Alzheimers Dis Relat Dement"},{"key":"10.3233\/JAD-180005_ref68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2015.03.025","article-title":"Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders","volume":"85","author":"Verkhratsky","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-180005_ref69","doi-asserted-by":"crossref","first-page":"a020560","DOI":"10.1101\/cshperspect.a020560","article-title":"Microglia in health and disease","volume":"8","author":"Ransohoff","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.3233\/JAD-180005_ref70","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180005_ref71","volume-title":"Mechanisms of Neuroinflammation","author":"Andrade","year":"2017"},{"key":"10.3233\/JAD-180005_ref72","volume-title":"Update on Dementia","author":"Morales","year":"2016"},{"key":"10.3233\/JAD-180005_ref73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fnint.2013.00059","article-title":"Inflammatory process in Alzheimer\u2019s Disease","volume":"7","author":"Meraz-Rios","year":"2013","journal-title":"Front Integr Neurosci"},{"key":"10.3233\/JAD-180005_ref74","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000258724","article-title":"Neuroimmunomodulation in the pathogenesis of Alzheimer\u2019s disease","volume":"17","author":"Morales","year":"2010","journal-title":"Neuroimmunomodulation"},{"key":"10.3233\/JAD-180005_ref75","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-180005_ref76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.11.003","article-title":"Functional polarization of neuroglia: Implications in neuroinflammation and neurological disorders","volume":"103","author":"Jha","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.3233\/JAD-180005_ref77","doi-asserted-by":"crossref","first-page":"a006346","DOI":"10.1101\/cshperspect.a006346","article-title":"Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature","volume":"2","author":"Wyss-Coray","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-180005_ref78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","article-title":"Inflammation in neurodegenerative disease\u2013a double-edged sword","volume":"35","author":"Wyss-Coray","year":"2002","journal-title":"Neuron"},{"key":"10.3233\/JAD-180005_ref79","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conb.2015.10.004","article-title":"Microglial genes regulating neuroinflammation in the progression of Alzheimer\u2019s disease","volume":"36","author":"Villegas-Llerena","year":"2016","journal-title":"Curr Opin Neurobiol"},{"key":"10.3233\/JAD-180005_ref80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature14252","article-title":"Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease","volume":"518","author":"Gjoneska","year":"2015","journal-title":"Nature"},{"key":"10.3233\/JAD-180005_ref81","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"Complement and microglia mediate early synapse loss in Alzheimer mouse models","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.3233\/JAD-180005_ref82","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nn.3641","article-title":"Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior","volume":"17","author":"Zhan","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-180005_ref83","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1177\/0963689717714098","article-title":"Inflammation relates to chronic behavioral and neurological symptoms in military personnel with traumatic brain injuries","volume":"26","author":"Devoto","year":"2017","journal-title":"Cell Transplant"},{"key":"10.3233\/JAD-180005_ref84","doi-asserted-by":"crossref","first-page":"ra110","DOI":"10.1126\/scisignal.aah7102","article-title":"A unique type of GSK-3 inhibitor brings new opportunities to the clinic","volume":"9","author":"Licht-Murava","year":"2016","journal-title":"Sci Signal"},{"key":"10.3233\/JAD-180005_ref85","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbi.2016.01.003","article-title":"Mood disturbance during experimental endotoxemia: Predictors of state anxiety as a psychological component of sickness behavior","volume":"57","author":"Lasselin","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-180005_ref86","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.0b013e318225ae07","article-title":"Proinflammatory cytokines, sickness behavior, and Alzheimer disease","volume":"77","author":"Holmes","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-180005_ref87","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainresbull.2014.09.003","article-title":"Neuropsychiatric symptoms in dementia-a role for neuroinflammation?","volume":"108","author":"Holmgren","year":"2014","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-180005_ref88","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: When the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-180005_ref89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/brbi.2000.0613","article-title":"Cytokine-induced sickness behavior: Where do we stand?","volume":"15","author":"Dantzer","year":"2001","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-180005_ref90","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/brain\/awv081","article-title":"Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain","volume":"138","author":"Maphis","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-180005_ref91","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","article-title":"Sustained interleukin-1beta overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model","volume":"33","author":"Ghosh","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180005_ref92","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","article-title":"CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer\u2019s disease mouse models","volume":"177","author":"Lee","year":"2010","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-180005_ref93","doi-asserted-by":"crossref","first-page":"e28330","DOI":"10.1371\/journal.pone.0028330","article-title":"Dose-dependent effects of endotoxin on neurobehavioral functions in humans","volume":"6","author":"Grigoleit","year":"2011","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180005_ref94","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.biopsych.2009.03.015","article-title":"Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity","volume":"66","author":"Harrison","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-180005_ref95","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0893-133X(00)00226-8","article-title":"Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents","volume":"24","author":"Yirmiya","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-180005_ref96","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pneurobio.2012.06.010","article-title":"The serotonergic system in ageing and Alzheimer\u2019s disease","volume":"99","author":"Rodriguez","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-180005_ref97","first-page":"316","article-title":"Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer\u2019s disease (DAT): Lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT","volume":"10","author":"Bonaccorso","year":"1998","journal-title":"Aging (Milano)"},{"key":"10.3233\/JAD-180005_ref98","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by Alzheimer\u2019s amyloid-beta oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180005_ref99","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/aww017","article-title":"Early and protective microglial activation in Alzheimer\u2019s disease: A prospective study using 18F-DPA-714 PET imaging","volume":"139","author":"Hamelin","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-180005_ref100","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers","volume":"8","author":"Suarez-Calvet","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-180005_ref101","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nbd.2017.05.007","article-title":"Molecular imaging of serotonin degeneration in mild cognitive impairment","volume":"105","author":"Smith","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-180005_ref102","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.euroneuro.2013.05.006","article-title":"The potential role of dopamine D(3) receptor neurotransmission in cognition","volume":"23","author":"Nakajima","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.3233\/JAD-180005_ref103","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jad.2011.05.057","article-title":"Hippocampal atrophy in first episode depression: A meta-analysis of magnetic resonance imaging studies","volume":"134","author":"Cole","year":"2011","journal-title":"J Affect Disord"},{"key":"10.3233\/JAD-180005_ref104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-151129","article-title":"Shared genetic risk factors for late-life depression and Alzheimer\u2019s disease","volume":"52","author":"Ye","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180005_ref105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jns.2016.09.053","article-title":"Role of neurodevelopment involved genes in psychiatric comorbidities and modulation of inflammatory processes in Alzheimer\u2019s disease","volume":"370","author":"Stefano","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-180005_ref106","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-200301200-00014","article-title":"Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders","volume":"14","author":"Kovacs","year":"2003","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-180005_ref107","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuropsychologia.2004.06.007","article-title":"Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer\u2019s disease","volume":"43","author":"Garcia-Alloza","year":"2005","journal-title":"Neuropsychologia"},{"key":"10.3233\/JAD-180005_ref108","first-page":"77","article-title":"The role of serotonin receptors in Alzheimer\u2019s disease","volume":"2","author":"Butzlaff","year":"2016","journal-title":"Opera Med Physiol"},{"key":"10.3233\/JAD-180005_ref109","doi-asserted-by":"crossref","first-page":"26716","DOI":"10.18632\/oncotarget.5777","article-title":"Serotonin 6 receptor controls Alzheimer\u2019s disease and depression","volume":"6","author":"Yun","year":"2015","journal-title":"Oncotarget"},{"key":"10.3233\/JAD-180005_ref110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","article-title":"Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients","volume":"203","author":"Storga","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-180005_ref111","doi-asserted-by":"crossref","first-page":"14727","DOI":"10.1038\/ncomms14727","article-title":"Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease","volume":"8","author":"Nobili","year":"2017","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-180005_ref112","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrn3381","article-title":"The brain reward circuitry in mood disorders","volume":"14","author":"Russo","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-180005_ref113","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.biopsych.2014.03.013","article-title":"Presynaptic D2 dopamine receptors control long-term depression expression and memory processes in the temporal hippocampus","volume":"77","author":"Rocchetti","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-180005_ref114","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3233\/JAD-131843","article-title":"Tau oligomers and fibrils induce activation of microglial cells","volume":"37","author":"Morales","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180005_ref115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jad.2017.03.074","article-title":"Increased dopamine receptor expression and anti-depressant response following deep brain stimulation of the medial forebrain bundle","volume":"217","author":"Dandekar","year":"2017","journal-title":"J Affect Disord"},{"key":"10.3233\/JAD-180005_ref116","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.euroneuro.2008.07.012","article-title":"Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: Similar actions of D(1) receptor agonists, but not of D(2) antagonists","volume":"19","author":"Loiseau","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.3233\/JAD-180005_ref117","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/npp.2011.254","article-title":"Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: A key role for the prefrontal cortex","volume":"37","author":"Watson","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-180005_ref118","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1559-4564.2006.06035.x","article-title":"Treating the cardiometabolic syndrome: An opportunity to provide comprehensive cardiovascular risk reduction","volume":"1","author":"Basile","year":"2006","journal-title":"J Cardiometab Syndr"},{"key":"10.3233\/JAD-180005_ref119","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(91)91456-B","article-title":"Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D2 receptor mRNA","volume":"564","author":"Bouthenet","year":"1991","journal-title":"Brain Res"},{"key":"10.3233\/JAD-180005_ref120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1096-9861(19981221)402:3<353::AID-CNE5>3.0.CO;2-4","article-title":"Differential regional and cellular distribution of dopamine D2-like receptors: An immunocytochemical study of subtype-specific antibodies in rat and human brain","volume":"402","author":"Khan","year":"1998","journal-title":"J Comp Neurol"},{"key":"10.3233\/JAD-180005_ref121","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-328X(95)00112-6","article-title":"Regional quantification of D1, D2, and D3 dopamine receptor mRNA in rat brain using a ribonuclease protection assay","volume":"33","author":"Richtand","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.3233\/JAD-180005_ref122","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-3565(24)39024-X","article-title":"Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: Evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals","volume":"295","author":"Stanwood","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-180005_ref123","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1523\/JNEUROSCI.4288-04.2005","article-title":"Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): Kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133","volume":"25","author":"Lee","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-180005_ref124","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187152706784111551","article-title":"The dopamine D3 receptor: A therapeutic target for the treatment of neuropsychiatric disorders","volume":"5","author":"Sokoloff","year":"2006","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.3233\/JAD-180005_ref125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1101\/lm.026070.112","article-title":"Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer\u2019s disease","volume":"19","author":"Guzman-Ramos","year":"2012","journal-title":"Learn Mem"},{"key":"10.3233\/JAD-180005_ref126","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/hipo.22044","article-title":"Characterization of dopamine D1 and D2 receptor-expressing neurons in the mouse hippocampus","volume":"22","author":"Gangarossa","year":"2012","journal-title":"Hippocampus"},{"key":"10.3233\/JAD-180005_ref127","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2005.05.002","article-title":"The hippocampal-VTA loop: Controlling the entry of information into long-term memory","volume":"46","author":"Lisman","year":"2005","journal-title":"Neuron"},{"key":"10.3233\/JAD-180005_ref128","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.biopsych.2012.08.027","article-title":"Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity","volume":"73","author":"McCormick","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-180005_ref129","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nature06041","article-title":"Behavioural improvements with thalamic stimulation after severe traumatic brain injury","volume":"448","author":"Schiff","year":"2007","journal-title":"Nature"},{"key":"10.3233\/JAD-180005_ref130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.expneurol.2010.06.022","article-title":"Deep brain stimulation of the nucleus accumbens shell increases impulsive behavior and tissue levels of dopamine and serotonin","volume":"225","author":"Sesia","year":"2010","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-180005_ref131","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/02699059009026185","article-title":"Deep-brain stimulation in a persistent vegetative state: Follow-up results and criteria for selection of candidates","volume":"4","author":"Tsubokawa","year":"1990","journal-title":"Brain Inj"},{"key":"10.3233\/JAD-180005_ref132","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2010.5.FOCUS10110","article-title":"Development of intraoperative electrochemical detection: Wireless instantaneous neumical concentration sensor for deep brain stimulation feedback","volume":"29","author":"Van Gompel","year":"2010","journal-title":"Neurosurg Focus"},{"key":"10.3233\/JAD-180005_ref133","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mehy.2011.04.014","article-title":"Neurotransmitters in disorders of consciousness and brain damage","volume":"77","author":"Clauss","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.3233\/JAD-180005_ref134","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/02699050802649662","article-title":"Fast awakening from minimally conscious state with apomorphine","volume":"23","author":"Fridman","year":"2009","journal-title":"Brain Inj"},{"key":"10.3233\/JAD-180005_ref135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/026990598122386","article-title":"Amantadine: A potential treatment for the minimally conscious state","volume":"12","author":"Zafonte","year":"1998","journal-title":"Brain Inj"},{"key":"10.3233\/JAD-180005_ref136","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/geronj\/48.2.P87","article-title":"Automatic and effortful memory processes in depressed persons.P","volume":"48","author":"Rohling","year":"1993","journal-title":"J Gerontol"},{"key":"10.3233\/JAD-180005_ref137","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40265-017-0702-8","article-title":"Ketamine and beyond: Investigations into the potential of glutamatergic agents to treat depression","volume":"77","author":"Lener","year":"2017","journal-title":"Drugs"},{"key":"10.3233\/JAD-180005_ref138","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.clinph.2016.03.005","article-title":"Electroencephalogram signatures of ketamine anesthesia-induced unconsciousness","volume":"127","author":"Akeju","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"10.3233\/JAD-180005_ref139","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00000542-197204000-00004","article-title":"The EEG, evoked potentials, and single-unit activity during ketamine anesthesia in cats","volume":"36","author":"Kayama","year":"1972","journal-title":"Anesthesiology"},{"key":"10.3233\/JAD-180005_ref140","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1152\/jn.00072.2012","article-title":"NMDAR antagonist action in thalamus imposes delta oscillations on the hippocampus","volume":"107","author":"Zhang","year":"2012","journal-title":"J Neurophysiol"},{"key":"10.3233\/JAD-180005_ref141","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hipo.1068","article-title":"Neuroimaging studies of the hippocampus in schizophrenia","volume":"11","author":"Heckers","year":"2001","journal-title":"Hippocampus"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:00Z","timestamp":1777370820000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180005"}},"subtitle":[],"editor":[{"given":"Harish","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":141,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-180005","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]}}}